Tech Company Financing Transactions

Mineralys Therapeutics Funding Round

On 6/8/2022, Mineralys Therapeutics raised $118 million in Series B funding from Andera Partners, RA Capital and Adams Street Partners.

Transaction Overview

Announced On
Transaction Type
Venture Equity
Series B
Proceeds Purpose
Mineralys plans to use the proceeds to continue to advance MLS-101, a highly selective aldosterone synthase inhibitor. MLS-101 is currently being evaluated in a Phase 2 clinical trial, called Target-HTN, for patients with uncontrolled hypertension. The Company anticipates releasing the top-line results of Target-HTN later this year.

Company Information

Company Status
Private & Independent
Mailing Address
150 N. Radnor Chester Rd. F200
Radnor, PA 19087
Email Address
Mineralys Therapeutics is a private, clinical-stage biopharmaceutical company committed to developing best-in-class, novel therapy for the treatment of hypertension. We are driven to bring a targeted approach to the management of hypertension.
Mineralys Therapeutics LinkedIn Company Profile
Social Media
Mineralys Therapeutics Company Twitter Account
Company News
Mineralys Therapeutics News
Mineralys Therapeutics on Facebook
Mineralys Therapeutics on YouTube

Management Team

Email & Social
BT Slingsby
  BT Slingsby LinkedIn Profile  BT Slingsby Twitter Account  BT Slingsby News  BT Slingsby on Facebook
Chief Executive Officer
Jon Congleton
  Jon Congleton LinkedIn Profile  Jon Congleton Twitter Account  Jon Congleton News  Jon Congleton on Facebook
Chief Financial Officer
Adam Levy
  Adam Levy LinkedIn Profile  Adam Levy Twitter Account  Adam Levy News  Adam Levy on Facebook
Chief Medical Officer
David Rodman
  David Rodman LinkedIn Profile  David Rodman Twitter Account  David Rodman News  David Rodman on Facebook
VP - Operations
Jessica Ibbitson
  Jessica Ibbitson LinkedIn Profile  Jessica Ibbitson Twitter Account  Jessica Ibbitson News  Jessica Ibbitson on Facebook



Browse more venture capital transactions:

Prev: 6/8/2022: Front Financial venture capital transaction
Next: 6/8/2022: Nava Benefits venture capital transaction


Share this article


About Database of VC Transactions

We do our best to document every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The information comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary